NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 3 filers reported holding NEOGENOMICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $19,162,109 | -13.3% | 1,557,895 | +13.3% | 1.16% | -3.5% |
Q2 2023 | $22,092,763 | -7.7% | 1,374,783 | 0.0% | 1.20% | -15.3% |
Q1 2023 | $23,934,972 | +56.6% | 1,374,783 | -16.9% | 1.41% | +49.3% |
Q4 2022 | $15,287,977 | +131.1% | 1,654,543 | +115.4% | 0.95% | +126.6% |
Q3 2022 | $6,614,000 | -15.5% | 768,186 | -20.0% | 0.42% | -7.7% |
Q2 2022 | $7,823,000 | -33.0% | 959,858 | -0.1% | 0.45% | -12.2% |
Q1 2022 | $11,674,000 | -66.0% | 960,832 | -4.5% | 0.52% | -57.4% |
Q4 2021 | $34,328,000 | -28.8% | 1,006,088 | +0.7% | 1.21% | -27.5% |
Q3 2021 | $48,185,000 | +6.8% | 998,858 | 0.0% | 1.67% | +12.9% |
Q2 2021 | $45,118,000 | -21.4% | 998,858 | -16.0% | 1.48% | -22.4% |
Q1 2021 | $57,370,000 | -11.4% | 1,189,512 | -1.1% | 1.90% | -15.5% |
Q4 2020 | $64,760,000 | +34.0% | 1,202,817 | -8.2% | 2.25% | +5.2% |
Q3 2020 | $48,314,000 | +19.1% | 1,309,668 | 0.0% | 2.14% | +11.8% |
Q2 2020 | $40,574,000 | +23.0% | 1,309,668 | +9.6% | 1.92% | -7.4% |
Q1 2020 | $32,994,000 | -22.1% | 1,195,015 | -17.5% | 2.07% | +19.5% |
Q4 2019 | $42,361,000 | +24.6% | 1,448,248 | -18.6% | 1.73% | +15.0% |
Q3 2019 | $34,005,000 | -16.9% | 1,778,530 | -4.7% | 1.50% | -7.4% |
Q2 2019 | $40,935,000 | +6.7% | 1,865,759 | -0.5% | 1.63% | +5.7% |
Q1 2019 | $38,378,000 | +65.9% | 1,875,759 | +2.3% | 1.54% | +42.4% |
Q4 2018 | $23,131,000 | -3.2% | 1,834,369 | +17.8% | 1.08% | +34.0% |
Q3 2018 | $23,896,000 | +310.7% | 1,556,745 | +250.8% | 0.81% | +282.5% |
Q2 2018 | $5,818,000 | +152.4% | 443,806 | +57.1% | 0.21% | +134.4% |
Q1 2018 | $2,305,000 | -78.2% | 282,506 | -76.3% | 0.09% | -78.6% |
Q4 2017 | $10,566,000 | -15.1% | 1,192,601 | +6.7% | 0.42% | -18.9% |
Q3 2017 | $12,438,000 | +53.0% | 1,117,555 | +23.1% | 0.52% | +46.3% |
Q2 2017 | $8,131,000 | +13.6% | 907,529 | 0.0% | 0.35% | +7.9% |
Q1 2017 | $7,160,000 | +7.0% | 907,529 | +16.2% | 0.33% | +3.1% |
Q4 2016 | $6,690,000 | +28.5% | 780,678 | +23.2% | 0.32% | +20.0% |
Q3 2016 | $5,208,000 | +52.1% | 633,589 | +48.8% | 0.26% | +38.0% |
Q2 2016 | $3,424,000 | – | 425,820 | – | 0.19% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 1,785,605 | $86,138,000 | 34.19% |
PERKINS CAPITAL MANAGEMENT INC | 157,750 | $7,610,000 | 4.71% |
Blue Water Life Science Advisors, LP | 222,222 | $10,719,000 | 3.49% |
First Light Asset Management, LLC | 1,055,960 | $50,940,000 | 3.36% |
Ranger Investment Management | 810,956 | $39,121,000 | 2.09% |
Bullseye Asset Management LLC | 108,054 | $5,212,000 | 1.81% |
Lombard Odier Asset Management (Switzerland) SA | 584,281 | $28,186,000 | 1.75% |
EMERALD MUTUAL FUND ADVISERS TRUST | 998,858 | $48,185,000 | 1.67% |
EMERALD ADVISERS, LLC | 904,298 | $43,623,000 | 1.58% |
Soleus Capital Management, L.P. | 190,556 | $9,192,000 | 1.43% |